Patry, Christian http://orcid.org/0000-0002-1270-6508
Webb, Nicholas J. A.
Feißt, Manuel http://orcid.org/0000-0002-5016-9731
Krupka, Kai http://orcid.org/0000-0002-0409-5196
Becker, Jan http://orcid.org/0000-0003-2929-8085
Bald, Martin http://orcid.org/0000-0003-3378-2160
Antoniello, Benedetta http://orcid.org/0009-0002-7011-302X
Bilge, Ilmay http://orcid.org/0000-0002-4852-989X
Gulhan, Bora http://orcid.org/0000-0003-0236-5786
Hogan, Julien
Kanzelmeyer, Nele
Ozkaya, Ozan http://orcid.org/0000-0002-0198-1221
Büscher, Anja
Sellier-Leclerc, Anne-Laure http://orcid.org/0000-0001-9902-0850
Shenoy, Mohan
Weber, Lutz T. http://orcid.org/0000-0003-4116-598X
Fichtner, Alexander http://orcid.org/0000-0002-9939-4059
Höcker, Britta http://orcid.org/0000-0003-4131-2273
Meier, Matthias
Tönshoff, Burkhard http://orcid.org/0000-0002-6598-6910
Funding for this research was provided by:
Novartis Pharma AG
Universitätsklinikum Heidelberg
Article History
Received: 30 May 2024
Revised: 2 July 2024
Accepted: 18 July 2024
First Online: 7 August 2024
Declarations
:
: Nicholas JA Webb and Matthias Meier are employees of Novartis, Basel, Switzerland. Burkhard Tönshoff has received research grants from Novartis, Astellas, and Chiesi, and consulting fees from Bristol-Myers Squibb, CSL Behring Biotherapies for Life, Vifor, and Chiesi. Lutz T. Weber has received research grants from Chiesi and lecture fees from Novartis, Alexion, and Chiesi. Jan U. Becker counsels Sanofi. Martin Bald received sponsoring for congress from Novartis and Alexion and speaker fees from Alexion.